rs994093288
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong
The NM_000251.3(MSH2):c.1759+9A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000644 in 1,242,848 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_000251.3 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250488Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135550
GnomAD4 exome AF: 0.00000642 AC: 7AN: 1090600Hom.: 0 Cov.: 16 AF XY: 0.00000714 AC XY: 4AN XY: 560248
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74382
ClinVar
Submissions by phenotype
not specified Benign:2
- -
- -
Lynch syndrome 1 Benign:1
This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. This variant has been observed in conjunction with multiple pathogenic variants, reducing the likelihood this variant itself is pathogenic. -
Hereditary nonpolyposis colorectal neoplasms Benign:1
- -
Malignant tumor of breast Benign:1
MSH2, EXON11, c.1759+9A>C, r.(spl?), Heterozygous, Likely BenignrnThe MSH2 c.1759+9A>C variant was not identified in the literature. The variant was identified in dbSNP (rs994093288) as “with likely benign allele”, ClinVar (classified as likely benign by Invitae and Color) and UMD-LSDB (observed 1x).The variant was identified in control databases in 1 of 245,714 chromosomes at a frequency of 0.000004 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the European population in 1 of 111,358 chromosomes (freq: 0.000009), but not in the African, Other, Latino, Ashkenazi Jewish, East Asian, Finnish, or South Asian populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. -
Hereditary cancer-predisposing syndrome Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at